dual agonist glp 1 glucagon New strategies for the treatment of obesity and metabolic dysfunctions Efficacy of glucagon-like peptide-1 and

Compared with nonusers, adults taking GLP-1s had a: 17 percent lower risk of venous thromboembolism, or blood clots in the veins 31 percent lower risk of pulmonary embolism, a potentially life-threatening clot that travels to the lungs 21 percent lower risk of going to the emergency department 44 percent lower risk of all-cause mortality (death from any cause) Researchers also observed lower stroke rates among GLP-1 users, although this difference didnt reach statistical significance

8 The following algorithm has been proposed for the management of patients taking GLP-1-RA presenting for surgery (Figure 2)

Diagnostic accuracy of point-of-care gastric ultrasound

Thus, the activation of Ras protein 1 and phospholipase C, as well as the activation of the IP3 and diacylglycerol (DAG) pathways (51)

Only 10-15% rests in telogen, waiting to shed and make room for new growth

Precaution for Use in People with Diabetic Retinopathy The prevalence of both CKD and diabetic retinopathy, a microvascular complication of diabetes, is known to increase proportionally to T2DM duration [47]